{"status": "OK", "response": {"docs": [{"type_of_material": "Op-Ed", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "Democrats accuse Republicans of delaying crime and health bills to make President Clinton look bad. But the truth is Democrats are rushing to judgment to avoid having to heed the voice of the people in an election only 12 weeks away. The crime bill, temporarily stymied by the gun lobby, is far from dead. That is not merely because a President and a majority leadership can use puissant patronage -- and a reprise of last year's \"Don't kill my young Presidency\" -- to snatch back the votes of enough of the 58 recalcitrant House Democrats to save the party from gridlockjaw.", "headline": {"main": "Essay; Why the Rush?"}, "abstract": null, "print_page": "15", "word_count": 687, "_id": "4fd1b6a88eb7c8105d6dd1d3", "snippet": "Democrats accuse Republicans of delaying crime and health bills to make President Clinton look bad. But the truth is Democrats are rushing to judgment to avoid having to heed the voice of the people in an election only 12 weeks away.   The crime...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1994/08/15/opinion/essay-why-the-rush.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "CLINTON, BILL"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "REFORM AND REORGANIZATION"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "LOBBYING AND LOBBYISTS"}, {"name": "subject", "value": "FIREARMS"}, {"name": "subject", "value": "CRIME AND CRIMINALS"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "William", "lastname": "SAFIRE"}], "original": "By WILLIAM SAFIRE"}, "document_type": "article", "pub_date": "1994-08-15T00:00:00Z", "section_name": "Health; Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "The companies that make and market a genetically engineered drug face charges that they have crossed legal and ethical lines in promoting their product, in the process tainting trusted relationships between doctors and patients, and parents and school systems. The drug is Protropin, a genetically engineered version of human growth hormone made by Genentech Inc. that can make some short children grow taller than they otherwise would. A Federal grand jury in Minneapolis this month indicted a doctor, David R. Brown of Minneapolis, on charges that he had received $1.1 million in kickbacks to prescribe the drug.", "headline": {"main": "Selling Growth Drug for Children: The Legal and Ethical Questions"}, "abstract": null, "print_page": "1", "word_count": 1710, "_id": "4fd1be808eb7c8105d6ec1b7", "snippet": "The companies that make and market a genetically engineered drug face charges that they have crossed legal and ethical lines in promoting their product, in the process tainting trusted relationships between doctors and patients, and parents and...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1994/08/15/us/selling-growth-drug-for-children-the-legal-and-ethical-questions.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "JENNINGS, EDMON R"}, {"name": "persons", "value": "BROWN, DAVID R"}, {"name": "organizations", "value": "CAREMARK INC"}, {"name": "organizations", "value": "GENENTECH INC"}, {"name": "subject", "value": "HORMONES"}, {"name": "subject", "value": "HEIGHT (STATURE)"}, {"name": "subject", "value": "PROTROPIN (HORMONE)"}, {"name": "subject", "value": "MARKETING AND MERCHANDISING"}, {"name": "subject", "value": "KICKBACKS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "CHILDREN AND YOUTH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Gina", "lastname": "KOLATA"}], "original": "By GINA KOLATA"}, "document_type": "article", "pub_date": "1994-08-15T00:00:00Z", "section_name": "Front Page; Health; U.S."}, {"type_of_material": "An Analysis; News Analysis", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Predicting the course of the health care bill has become a minor industry in the nation's capital, but rarely have its prospects been more difficult to read. Just 86 days before the midterm elections, nobody knows when the Senate will finish its work or when the House will begin.", "headline": {"main": "Senate Now Has Main Role on Health", "kicker": "THE HEALTH CARE DEBATE: THE LEGISLATION"}, "abstract": null, "print_page": "12", "word_count": 990, "_id": "4fd1b6a88eb7c8105d6dd1ce", "snippet": "Predicting the course of the health care bill has become a minor industry in the nation's capital, but rarely have its prospects been more difficult to read.   Just 86 days before the midterm elections, nobody knows when the Senate will finish its...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/1994/08/15/us/the-health-care-debate-the-legislation-senate-now-has-main-role-on-health.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "REFORM AND REORGANIZATION"}, {"name": "subject", "value": "HEALTH INSURANCE"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Robin", "lastname": "TONER"}], "original": "By ROBIN TONER"}, "document_type": "article", "pub_date": "1994-08-15T00:00:00Z", "section_name": "Health; U.S."}], "meta": {"hits": 63, "offset": 60, "time": 36}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}